Latest Organ failure Stories

SCOTTSDALE, Ariz., June 13, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company, today announced that it has secured exclusive licensing rights to Palmitoylethanolamide (PEA), including the micronized and ultra-micronized forms, a novel non-steroidal, kidney-friendly anti-inflammatory and anti-fibrotic agent with a well-documented safety profile in humans. Commenting on securing the rights to this important new agent, Prismic's...

Recent research has found that patients with kidney disease can benefit tremendously from living a healthy lifestyle, meaning that weight control supplements like Prescopodene by Prescopodene Nutritionals might contribute to a longer life in people with these types of conditions. Australia (PRWEB) June 06, 2013 Several studies have been completed regarding healthy diet and its effect on the heart. However, one has now focused on the positive effects of healthy living for people suffering...

As many as 39 recently diagnosed heart failure patients who meet specified health and financial-need criteria can participate -- free of charge -- in a four-month exercise rehabilitation program cooperatively administered by the Congestive Heart Failure Clinic and Cardiac Rehabilitation program at St. Joseph Health Center. Warren, OH (PRWEB) June 06, 2013 Recently diagnosed heart failure patients in Trumbull County are benefiting from a Humility of Mary Health Partners pilot program...

Dialyspa dialysis centers address the questions and needs of those beginning dialysis treatments by offering personal tours and monthly support groups at each of their three Houston clinics. Houston, TX (PRWEB) June 04, 2013 Sometimes kidneys can decrease in function over a period of time, such as when someone has Chronic Kidney Disease (CKD) or Polycystic Kidney Disease (PKD). Other times kidneys fail unexpectedly due to trauma, reaction to medications or other situations that damage...

Researchers have found that conditions in the womb can affect kidney development and have serious health implications for the child not only immediately after birth, but decades later. In a paper published today in The Lancet an international team, including Monash University's Professor John Bertram and the University of Queensland's Professor Wendy Hoy, reviewed existing, peer-reviewed research on kidney health and developmental programming - the effects of the in utero environment on...

SAN DIEGO, May 29, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases announced today it had been selected as a winner of Red Herring's Top 100 North America award, a prestigious list honoring the year's most promising private technology ventures from the North American business region. "We are proud to have been selected as a winner of this award and we are thankful to...

- Patients, physicians and public are invited to attend the event on May 30 EL PASO, Texas, May 29, 2013 /PRNewswire/ -- DSI Renal, a leading provider of dialysis services for patients suffering from chronic kidney failure, announced today that the DSI El Paso South Dialysis Center will host an official Grand Opening and Community Open House event on Thursday, May 30, 2013, from 4:00-8:00 pm. Members of the community, along with dialysis patients, family members and physicians, are...

Behaviors that protect the heart may also prolong patients' lives Maintaining a heart healthy lifestyle may also help protect chronic kidney disease patients from developing kidney failure and dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings suggest that patients with kidney disease should be encouraged to improve their heart health. Poor kidney health puts people at risk of developing heart...

AbbVie presents results of Phase 2b studies NORTH CHICAGO, Ill., May 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease (CKD) and type 2 diabetes. SONAR is a large, multinational,...

BOSTON, May 17, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest update for their competitive landscape map for the Chronic Kidney Disease (CKD) market. This particular landscape highlights over 90 international companies with drugs and devices currently on the market and in development addressing CKD and its sequelae. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) Topics include: hypertension - renal denervation diabetic nephropathy...